GSDME Gene Deafness Autosomal Dominant Type 5 Genetic Test sale cost 4400 AED
GJB3 Gene Deafness Autosomal Dominant Type 2B Genetic Test sale cost 4400 AED GJB3 Gene Deafness Autosomal Dominant Type 2B Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
FOXI1 Gene Deafness Autosomal Recessive Type 4 Genetic Test sale cost 4400 AED FOXI1 Gene Deafness Autosomal Recessive Type 4 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

GSDME Gene Deafness Autosomal Dominant Type 5 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GSDME Gene Deafness Autosomal Dominant Type 5 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the GSDME gene that are associated with Autosomal Dominant Deafness Type 5 (DFNA5). This form of hearing loss is characterized by its genetic inheritance pattern, where a single copy of the mutated gene from an affected parent can lead to the condition in the offspring. The test plays a crucial role in the early detection and management of this type of hearing impairment, facilitating informed decisions regarding treatment options and preventive measures for at-risk family members. Priced at 4400 AED, this genetic test involves analyzing the individual’s DNA to detect specific mutations in the GSDME gene, providing a comprehensive understanding of the genetic basis of their condition. By opting for this test at DNA Labs UAE, patients can expect accurate results, professional consultation, and guidance on the implications of their genetic profile in relation to Autosomal Dominant Deafness Type 5.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GSDME Gene Deafness Autosomal Dominant Type 5 Genetic Test

At DNA Labs UAE, we offer the GSDME Gene Deafness Autosomal Dominant Type 5 Genetic Test. This test is designed to detect mutations in the GSDME gene, which is associated with a form of genetic deafness known as autosomal dominant type 5 (DFNA5).

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the GSDME Gene Deafness Autosomal Dominant Type 5 Genetic Test, it is important to provide the clinical history of the patient. This includes any relevant information about the patient’s condition and symptoms. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A6.

Test Details

The GSDME gene, also known as Gasdermin E, is associated with autosomal dominant type 5 (DFNA5) genetic deafness. This means that a mutation in one copy of the GSDME gene is enough to cause the condition. The Next-Generation Sequencing (NGS) technology is used to sequence the entire coding region of the GSDME gene and identify any mutations or variations that may be present.

The gasdermin E protein, encoded by the GSDME gene, plays a role in cell death and inflammation. Mutations in this gene can disrupt the normal function of the protein, leading to the death of certain cells in the inner ear and resulting in progressive hearing loss.

Genetic testing for GSDME-related deafness can help confirm a diagnosis in individuals suspected to have DFNA5 and identify family members who may be at risk of inheriting the condition. This information is valuable for genetic counseling, family planning, and potentially for developing targeted treatment approaches in the future.

Test Name GSDME Gene Deafness autosomal dominant type 5 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A6
Test Details

GSDME (Gasdermin E) is a gene associated with a form of genetic deafness called autosomal dominant type 5 (DFNA5). This type of deafness is inherited in an autosomal dominant manner, meaning that a mutation in one copy of the GSDME gene is sufficient to cause the condition.

NGS (Next-Generation Sequencing) is a high-throughput technology used for genetic testing. In the context of GSDME-related deafness, NGS can be used to sequence the entire coding region of the GSDME gene and identify any mutations or variations that may be present.

The GSDME gene encodes the gasdermin E protein, which is involved in cell death and inflammation. Mutations in this gene can disrupt the normal function of the protein and lead to the death of certain cells in the inner ear, resulting in progressive hearing loss.

Genetic testing for GSDME-related deafness can help confirm a diagnosis in individuals with suspected DFNA5 and identify family members who may be at risk of inheriting the condition. This information can be useful for genetic counseling, family planning, and potentially for developing targeted treatment approaches in the future.

SKU: TEST-2694 Category:

Related products